SCHEMBL8690458

SCHEMBL8690458

O=Cc1cn(CC(=O)c2ccccc2)c2ccccc12

nearest known ligand 0.65

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.65
MEN1 O00255 4/20 0.65
ALDH1A1 P00352 7/20 0.61
SMN1; SMN2 Q16637 6/20 0.56
L3MBTL1 Q9Y468 1/20 0.54
POLB P06746 1/20 0.53
HTT P42858 4/20 0.52
LMNA P02545 2/20 0.52
MAPT P10636 2/20 0.52
NPC1 O15118 1/20 0.52
HPGD P15428 1/20 0.52
RAB9A P51151 1/20 0.52
GAA P10253 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29952467 0.86 ALDH1A1 (0.66) KMT2AMEN1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL1250173 0.86 ALDH1A1 (0.66) KMT2AMEN1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL8685214 0.83 KMT2A (0.51) KMT2AMEN1ALDH1A1SMN1; SMN2POLB
SCHEMBL30718481 0.82 ALDH1A1 (0.64) KMT2AMEN1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL1520957 0.82 ALDH1A1 (0.64) KMT2AMEN1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL29277395 0.80 ALDH1A1 (0.59) KMT2AMEN1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL14450860 0.79 ALDH1A1 (0.61) KMT2AMEN1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL15331580 0.79 MEN1 (0.83) KMT2AMEN1ALDH1A1SMN1; SMN2POLB
SCHEMBL6224417 0.79 KMT2A (1.00) KMT2AMEN1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL5475563 0.78 ALDH1A1 (0.76) KMT2AMEN1ALDH1A1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079102-A1 INDOLYL-PIPERIDINYL BENZYLAMINES AS BETA-TRYPTASE INHIBITORS SANOFI (FR) 2011-06-30 WO disclosed
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 US disclosed
CN-1167111-A Thiazolidinedione derivatives, method for preparing derivatives and pharmaceutical compositions containing same SENGA PHARMACEUTICAL LAB INC (JP) 1997-12-10 CN disclosed
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 EP disclosed